年間 4 号発行
ISSN 印刷: 0893-9675
ISSN オンライン: 2162-6448
Indexed in
Cellular Iron Metabolism in Prognosis and Therapy of Breast Cancer
要約
Despite many recent advances, breast cancer remains a clinical challenge. Current issues include improving prognostic evaluation and increasing therapeutic options for women whose tumors are refractory to current frontline therapies. Iron metabolism is frequently disrupted in breast cancer, and may offer an opportunity to address these challenges. Iron enhances breast tumor initiation, growth and metastases. Iron may contribute to breast tumor initiation by promoting redox cycling of estrogen metabolites. Up-regulation of iron import and down-regulation of iron export may enable breast cancer cells to acquire and retain excess iron. Alterations in iron metabolism in macrophages and other cells of the tumor microenvironment may also foster breast tumor growth. Expression of iron metabolic genes in breast tumors is predictive of breast cancer prognosis. Iron chelators and other strategies designed to limit iron may have therapeutic value in breast cancer. The dependence of breast cancer on iron presents rich opportunities for improved prognostic evaluation and therapeutic intervention.
-
Xiong Wei, Wang Li, Yu Fenglei, Regulation of cellular iron metabolism and its implications in lung cancer progression, Medical Oncology, 31, 7, 2014. Crossref
-
Guo Wenli, Zhang Shuping, Chen Yue, Zhang Daoqiang, Yuan Lin, Cong Haibo, Liu Sijin, An important role of the hepcidin–ferroportin signaling in affecting tumor growth and metastasis, Acta Biochimica et Biophysica Sinica, 47, 9, 2015. Crossref
-
Chekhun Vasyl’, Lukianova Natalia, Demash Dmytro, Borikun Tetiana, Chekhun Svyatoslav, Shvets Yulia, Manifestation of Key Molecular Genetic Markers in Pharmacocorrection of Endogenous Iron Metabolism in MCF-7 and MCF-7/DDP Human Breast Cancer Cells, CellBio, 02, 04, 2013. Crossref
-
Qian Yi, Yin Chunyang, Chen Yue, Zhang Shuping, Jiang Li, Wang Fudi, Zhao Meirong, Liu Sijin, Estrogen contributes to regulating iron metabolism through governing ferroportin signaling via an estrogen response element, Cellular Signalling, 27, 5, 2015. Crossref
-
Power Coombs Melanie R., Grant Taryn, Greenshields Anna L., Arsenault Daniel J., Holbein Bruce E., Hoskin David W., Inhibitory effect of iron withdrawal by chelation on the growth of human and murine mammary carcinoma and fibrosarcoma cells, Experimental and Molecular Pathology, 99, 2, 2015. Crossref
-
Khan Parvez, Prakash Amresh, Haque Md. Anzarul, Islam Asimul, Hassan Md. Imtaiyaz, Ahmad Faizan, Structural basis of urea-induced unfolding: Unraveling the folding pathway of hemochromatosis factor E, International Journal of Biological Macromolecules, 91, 2016. Crossref
-
Kazan Hasan Huseyin, Urfali-Mamatoglu Cagri, Gunduz Ufuk, Iron metabolism and drug resistance in cancer, BioMetals, 30, 5, 2017. Crossref
-
Jung Michaela, Weigert Andreas, Mertens Christina, Rehwald Claudia, Brüne Bernhard, Iron Handling in Tumor-Associated Macrophages—Is There a New Role for Lipocalin-2?, Frontiers in Immunology, 8, 2017. Crossref
-
Mertens Christina, Akam Eman Abureida, Rehwald Claudia, Brüne Bernhard, Tomat Elisa, Jung Michaela, Singh Pankaj K, Intracellular Iron Chelation Modulates the Macrophage Iron Phenotype with Consequences on Tumor Progression, PLOS ONE, 11, 11, 2016. Crossref
-
Elnahas Marwa, Amin Magdy, Hussein Mohamed, Shanbhag Vinit, Ali Amal, Wall Judy, Isolation, Characterization and Bioactivities of an Extracellular Polysaccharide Produced from Streptomyces sp. MOE6, Molecules, 22, 9, 2017. Crossref
-
Rosager Ann Mari, Sørensen Mia D., Dahlrot Rikke H., Hansen Steinbjørn, Schonberg David L., Rich Jeremy N., Lathia Justin D., Kristensen Bjarne W., Fillmore Helen, Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: Expression and prognostic value, PLOS ONE, 12, 8, 2017. Crossref
-
El Hout Mouradi, Dos Santos Leïla, Hamaï Ahmed, Mehrpour Maryam, A promising new approach to cancer therapy: Targeting iron metabolism in cancer stem cells, Seminars in Cancer Biology, 53, 2018. Crossref
-
Rejmund Marta, Mrozek-Wilczkiewicz Anna, Malarz Katarzyna, Pyrkosz-Bulska Monika, Gajcy Kamila, Sajewicz Mieczyslaw, Musiol Robert, Polanski Jaroslaw, Palit Deb Swati, Piperazinyl fragment improves anticancer activity of Triapine, PLOS ONE, 13, 4, 2018. Crossref
-
Jakubaszek Marta, Goud Bruno, Ferrari Stefano, Gasser Gilles, Mechanisms of action of Ru(ii) polypyridyl complexes in living cells upon light irradiation, Chemical Communications, 54, 93, 2018. Crossref
-
Chua Anita CG, Knuiman Matthew W, Trinder Debbie, Divitini Mark L, Olynyk John K, Higher concentrations of serum iron and transferrin saturation but not serum ferritin are associated with cancer outcomes, The American Journal of Clinical Nutrition, 104, 3, 2016. Crossref
-
Yang Jie, Li Wei, Luo Lihua, Jiang Mengshi, Zhu Chunqi, Qin Bing, Yin Hang, Yuan Xiaoling, Yin Xiaoyi, Zhang Junlei, Luo Zhenyu, Du Yongzhong, You Jian, Hypoxic tumor therapy by hemoglobin-mediated drug delivery and reversal of hypoxia-induced chemoresistance, Biomaterials, 182, 2018. Crossref
-
Bajbouj Khuloud, Shafarin Jasmin, Hamad Mawieh, High-Dose Deferoxamine Treatment Disrupts Intracellular Iron Homeostasis, Reduces Growth, and Induces Apoptosis in Metastatic and Nonmetastatic Breast Cancer Cell Lines, Technology in Cancer Research & Treatment, 17, 2018. Crossref
-
Greenshields Anna L., Power Coombs Melanie R., Fernando Wasundara, Holbein Bruce E., Hoskin David W., DIBI, a novel 3-hydroxypyridin-4-one chelator iron-binding polymer, inhibits breast cancer cell growth and functions as a chemosensitizer by promoting S-phase DNA damage, BioMetals, 32, 6, 2019. Crossref
-
Petrosino Maria, Pasquo Alessandra, Novak Leonore, Toto Angelo, Gianni Stefano, Mantuano Elide, Veneziano Liana, Minicozzi Velia, Pastore Annalisa, Puglisi Rita, Capriotti Emidio, Chiaraluce Roberta, Consalvi Valerio, Characterization of human frataxin missense variants in cancer tissues, Human Mutation, 40, 9, 2019. Crossref
-
Mora Javier, Mertens Christina, Meier Julia K., Fuhrmann Dominik C., Brüne Bernhard, Jung Michaela, Strategies to Interfere with Tumor Metabolism through the Interplay of Innate and Adaptive Immunity, Cells, 8, 5, 2019. Crossref
-
Chang Vicky C., Cotterchio Michelle, Khoo Edwin, Iron intake, body iron status, and risk of breast cancer: a systematic review and meta-analysis, BMC Cancer, 19, 1, 2019. Crossref
-
Yaghoobi Fatemeh, Karimi shervedani Reza, Torabi Mostafa, Kefayat Amirhosein, Ghahremani Fatemeh, Farzadniya Amin, Therapeutic effect of deferrioxamine conjugated to PEGylated gold nanoparticles and complexed with Mn(II) beside the CT scan and MRI diagnostic studies, Colloids and Surfaces A: Physicochemical and Engineering Aspects, 583, 2019. Crossref
-
Gasparetto Maura, Pei Shanshan, Minhajuddin Mohammad, Stevens Brett, Smith Clayton A., Seligman Paul, Low ferroportin expression in AML is correlated with good risk cytogenetics, improved outcomes and increased sensitivity to chemotherapy, Leukemia Research, 80, 2019. Crossref
-
Pamphlett Roger, Satgunaseelan Laveniya, Kum Jew Stephen, Doble Philip A., Bishop David P., Hu Yi, Elemental bioimaging shows mercury and other toxic metals in normal breast tissue and in breast cancers, PLOS ONE, 15, 1, 2020. Crossref
-
Rychtarcikova Zuzana, Lettlova Sandra, Tomkova Veronika, Korenkova Vlasta, Langerova Lucie, Simonova Ekaterina, Zjablovskaja Polina, Alberich-Jorda Meritxell, Neuzil Jiri, Truksa Jaroslav, Tumor-initiating cells of breast and prostate origin show alterations in the expression of genes related to iron metabolism, Oncotarget, 8, 4, 2017. Crossref
-
Jiang Honglin, Muir Ryan K., Gonciarz Ryan L., Olshen Adam, Yeh Iwei, Hann Byron C., Zhao Ning, Wang Yung-hua, Behr Spencer C., Evans Michael J., Collisson Eric A., Renslo Adam R., Exploiting KRAS-Driven Ferroaddiction in Cancer Through Ferrous Iron-Activatable Drug Conjugates (FeADC), SSRN Electronic Journal , 2020. Crossref
-
Cheng Gang, Zielonka Jacek, Hardy Micael, Ouari Olivier, Chitambar Christopher R., Dwinell Michael B., Kalyanaraman Balaraman, Synergistic inhibition of tumor cell proliferation by metformin and mito-metformin in the presence of iron chelators, Oncotarget, 10, 37, 2019. Crossref
-
Chen Gang , Guo Guangqi , Zhou Xiaodong , Chen Hongxia , Potential mechanism of ferroptosis in pancreatic cancer (Review), Oncology Letters, 2019. Crossref
-
Chen Ying, Fan Zhimin, Yang Ye, Gu Chunyan, Iron metabolism and its contribution to cancer (Review), International Journal of Oncology, 2019. Crossref
-
Shibabaw Tewodros, Teferi Banchamlak, Molla Meseret Derbew, Ayelign Birhanu, <p>Inflammation Mediated Hepcidin-Ferroportin Pathway and Its Therapeutic Window in Breast Cancer</p>, Breast Cancer: Targets and Therapy, Volume 12, 2020. Crossref
-
Henry Kelly E., Dilling Thomas R., Abdel-Atti Dalya, Edwards Kimberly J., Evans Michael J., Lewis Jason S., Noninvasive 89Zr-Transferrin PET Shows Improved Tumor Targeting Compared with 18F-FDG PET in MYC-Overexpressing Human Triple-Negative Breast Cancer, Journal of Nuclear Medicine, 59, 1, 2018. Crossref
-
Khan Rizwan Ullah, Hassan Amber, Tanvir Imrana, Ehsan Kashifa , Prognostic Signicance of Cellular Iron Metabolism in Breast Cancer , Pakistan BioMedical Journal, 1, 1, 2018. Crossref
-
Liu Kai-Yan, Feng Xiao-Li, Mo Xiong-Fei, Lin Fang-Yu, Zhang Xin, Huang Chu-Yi, Abulimiti Alinuer, Li Lei, Zhang Cai-Xia, Iron intake with the risk of breast cancer among Chinese women: a case–control study, Public Health Nutrition, 24, 17, 2021. Crossref
-
Xiaofei Jiang, Mingqing Shi, Miao Sui, Yizhen Yuan, Shuang Zhang, Qinhua Xia, Kai Zhao, Oleanolic acid inhibits cervical cancer Hela cell proliferation through modulation of the ACSL4 ferroptosis signaling pathway, Biochemical and Biophysical Research Communications, 545, 2021. Crossref
-
Yang Jianhui, Xu Jin, Zhang Bo, Tan Zhen, Meng Qingcai, Hua Jie, Liu Jiang, Wang Wei, Shi Si, Yu Xianjun, Liang Chen, Ferroptosis: At the Crossroad of Gemcitabine Resistance and Tumorigenesis in Pancreatic Cancer, International Journal of Molecular Sciences, 22, 20, 2021. Crossref
-
Qian Yi, Zhang Shuping, Guo Wenli, Ma Juan, Chen Yue, Wang Lei, Zhao Meirong, Liu Sijin, Polychlorinated Biphenyls (PCBs) Inhibit Hepcidin Expression through an Estrogen-Like Effect Associated with Disordered Systemic Iron Homeostasis, Chemical Research in Toxicology, 28, 4, 2015. Crossref
-
Gibbons Jessica A., Kanwar Jagat R., Kanwar Rupinder K., Iron-free and iron-saturated bovine lactoferrin inhibit survivin expression and differentially modulate apoptosis in breast cancer, BMC Cancer, 15, 1, 2015. Crossref
-
Crake Rebekah L. I., Burgess Eleanor R., Royds Janice A., Phillips Elisabeth, Vissers Margreet C. M., Dachs Gabi U., The Role of 2-Oxoglutarate Dependent Dioxygenases in Gliomas and Glioblastomas: A Review of Epigenetic Reprogramming and Hypoxic Response, Frontiers in Oncology, 11, 2021. Crossref
-
Wigner Paulina, Zielinski Krzysztof, Labieniec-Watala Magdalena, Marczak Agnieszka, Szwed Marzena, Doxorubicin–transferrin conjugate alters mitochondrial homeostasis and energy metabolism in human breast cancer cells, Scientific Reports, 11, 1, 2021. Crossref
-
Liu Zixuan, Xia Xiaomin, Lv Xuying, Song Erqun, Song Yang, Iron-bearing nanoparticles trigger human umbilical vein endothelial cells ferroptotic responses by promoting intracellular iron level, Environmental Pollution, 287, 2021. Crossref
-
Zhang Zheng, Jiang Hao-Jie, Yang Huan-Huan, Ren Jin-Jin, Jiang Guo-Qin, Xu Jia-Ying, Qin Li-Qiang, Growth differentiation factor-15 and lactoferrin immuno-expression in breast cancer: relationship with body iron-status and survival outcome, BioMetals, 34, 2, 2021. Crossref
-
Ali Amjad, Shafarin Jasmin, Abu Jabal Rola, Aljabi Nour, Hamad Mohamad, Sualeh Muhammad Jibran, Unnikannan Hema, Hamad Mawieh, Ferritin heavy chain (FTH1) exerts significant antigrowth effects in breast cancer cells by inhibiting the expression of c‐MYC, FEBS Open Bio, 11, 11, 2021. Crossref
-
Trudu Federica, Amato Filippo, Vaňhara Petr, Pivetta Tiziana, Peña-Méndez E.M., Havel Josef, Coordination compounds in cancer: Past, present and perspectives, Journal of Applied Biomedicine, 13, 2, 2015. Crossref
-
Dong Dandan, Zhang Gejing, Yang Jiancheng, Zhao Bin, Wang Shenghang, Wang Luyao, Zhang Ge, Shang Peng, The role of iron metabolism in cancer therapy focusing on tumor‐associated macrophages, Journal of Cellular Physiology, 234, 6, 2019. Crossref
-
Jiang Honglin, Muir Ryan K., Gonciarz Ryan L., Olshen Adam B., Yeh Iwei, Hann Byron C., Zhao Ning, Wang Yung-hua, Behr Spencer C., Korkola James E., Evans Michael J., Collisson Eric A., Renslo Adam R., Ferrous iron–activatable drug conjugate achieves potent MAPK blockade in KRAS-driven tumors, Journal of Experimental Medicine, 219, 4, 2022. Crossref
-
Zhu Liyun, Meng Danni, Wang Xu, Chen Xuerui, Ferroptosis-Driven Nanotherapeutics to Reverse Drug Resistance in Tumor Microenvironment, ACS Applied Bio Materials, 5, 6, 2022. Crossref
-
Kawabata Tsuyoshi, Yoshimori Tamotsu, Beyond starvation: An update on the autophagic machinery and its functions, Journal of Molecular and Cellular Cardiology, 95, 2016. Crossref
-
Jung Michaela, Mertens Christina, Bauer Rebekka, Rehwald Claudia, Brüne Bernhard, Lipocalin-2 and iron trafficking in the tumor microenvironment, Pharmacological Research, 120, 2017. Crossref
-
Qin Hong, Zeng Weibiao, Lou Yongfu, Mendelian randomization study indicates lack of causal associations between iron status and lung cancer, Medicine, 101, 29, 2022. Crossref
-
Chen Shuming, Li He, Chen Siyu, Wang Bing, Zhang Kaixiang, BMI1 promotes the proliferation and inhibits autophagy of breast cancer cells by activating COPZ1, Clinical and Translational Oncology, 24, 11, 2022. Crossref